Cite
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications
MLA
Arsalan Tariq, et al. “Urothelial Carcinoma and Prostate-Specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications.” European Urology Focus, vol. 8, Sept. 2022, pp. 1256–69. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dbb7704f81a45cdb4cba99758fa41f06&authtype=sso&custid=ns315887.
APA
Arsalan Tariq, Ian Vela, Sima P. Porten, Elizabeth D. Williams, John Yaxley, Peter C. Black, Amy E. McCart Reed, Andrew Morton, & Matthew J. Roberts. (2022). Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications. European Urology Focus, 8, 1256–1269.
Chicago
Arsalan Tariq, Ian Vela, Sima P. Porten, Elizabeth D. Williams, John Yaxley, Peter C. Black, Amy E. McCart Reed, Andrew Morton, and Matthew J. Roberts. 2022. “Urothelial Carcinoma and Prostate-Specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications.” European Urology Focus 8 (September): 1256–69. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dbb7704f81a45cdb4cba99758fa41f06&authtype=sso&custid=ns315887.